Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Director · Chief Executive Officer · 10% owner | August 25, 2026 | August 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date August 25, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2022 GRAT | 0 |
Reported balance
After 2026-08-25 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2026-08-25 · Gift · Disposed 463,289 · Balance 0 F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2022 GRAT | 463,289 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 463,289 F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Legacy 2021 Trust | 103,406 |
Reported balance
After 2026-08-27 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2026-08-27 · Other · Disposed 977,566 · Balance 103,406 F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes. |
| Class A Common StockSEC Table I · non-derivative | Direct | 1,033,177 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,033,177 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 | 573,202 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 573,202 F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2025 GRAT dated 5-27-2025 | 42,993 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 42,993 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Family Community Property Trust | 470,457 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 470,457 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2022 GRAT 2 dated 9/7/2022 | 791,117 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 791,117 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Family Heritage Trust UAD 8-10-2021 | 2,214,769 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 2,214,769 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Family 2021 Trust | 3,004,071 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 10
Holding and transaction disclosures are not merged.
1 source rowRow 10 · Balance 3,004,071 |
Filing footnotes · ownership attribution and instrument terms
F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.
F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person.
F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 15,945 | $58.50 | $932,835.12 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 11 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,270 F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F9 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.22 - $58.945. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 17,001 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · derivative · entry 26 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,009 Underlying: Class A Common Stock · 17,001 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F18 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 108,334 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · derivative · entry 25 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 864,731 Underlying: Class A Common Stock · 108,334 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F17 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 17,710 | $56.92 | $1,008,012.47 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 10 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 160,215 F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F8 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.79 - $57.26. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 90,624 | $56.39 | $5,110,196.74 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 9 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,925 F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.79 - $56.78. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 17,001 | $58.61 | $996,404.81 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 8 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,549 F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.79 - $56.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 17,001 | $2.43 | $41,312.43 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 7 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 285,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 108,334 | $2.43 | $263,251.62 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 6 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 7,414 | $56.90 | $421,870.69 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 5 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 237,660 F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.82 - $57.05. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 40,120 | $56.44 | $2,264,428.97 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 245,074 F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.83 - $56.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 2,792 | $56.35 | $157,336.46 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 160,215 F2 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.20 - $56.495. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 13, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 19,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · derivative · entry 24 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 287,256 Underlying: Class A Common Stock · 19,150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F16 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025. F16 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025. Read SEC document |
| June 13, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 74,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · derivative · entry 23 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 819,828 Underlying: Class A Common Stock · 74,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F15 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F15 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| June 13, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 35,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · derivative · entry 22 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 248,126 Underlying: Class A Common Stock · 35,446 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F14 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. F14 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. Read SEC document |
| June 13, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 35,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · derivative · entry 21 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,726 Underlying: Class A Common Stock · 35,242 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F13 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. F13 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. Read SEC document |
| June 13, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 90,672 | $55.48 | $5,030,482.56 |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 163,007 Read SEC document |
| June 13, 2025 Filed Jun 18, 2025 00:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 164,368 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-25-000222 · wk-form4_1750205217.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 253,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| May 16, 2025 Filed May 19, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 108,334 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · derivative · entry 19 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 973,065 Underlying: Class A Common Stock · 108,334 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F10 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. Read SEC document |
| May 16, 2025 Filed May 19, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 17,001 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · derivative · entry 18 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,010 Underlying: Class A Common Stock · 17,001 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F9 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| May 16, 2025 Filed May 19, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,427 | $59.21 | $380,534.96 |
DisclosureSEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 9 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,311 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F8 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.00 - $59.525. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 16, 2025 Filed May 19, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 52,642 | $58.67 | $3,088,500.88 |
DisclosureSEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 8 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,738 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.42 - $58.99. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 16, 2025 Filed May 19, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 49,265 | $57.84 | $2,849,610.76 |
DisclosureSEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 7 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 148,380 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.42 - $58.405. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 16, 2025 Filed May 19, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 108,334 | $2.43 | $263,251.62 |
DisclosureSEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 6 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 197,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| May 16, 2025 Filed May 19, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 17,001 | $58.72 | $998,285.12 |
DisclosureSEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 5 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,311 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.50 - $59.19. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 16, 2025 Filed May 19, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 17,001 | $2.43 | $41,312.43 |
DisclosureSEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| May 16, 2025 Filed May 19, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 22,227 | $58.70 | $1,304,771.58 |
DisclosureSEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 285,194 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.50 - $59.16. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 16, 2025 Filed May 19, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 25,307 | $57.86 | $1,464,202.28 |
DisclosureSEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 307,421 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.43 - $58.38. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 16, 2025 Filed May 19, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 2,792 | $59.27 | $165,482.12 |
DisclosureSEC source: 0001773751-25-000165 · wk-form4_1747694094.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,311 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.00 - $59.455. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 22:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000141 · wk-form4_1746050474.xml · derivative · entry 15 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,081,399 Underlying: Class A Common Stock · 50,000 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F3 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 22:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 50,000 | $36.39 | $1,819,310.00 |
DisclosureSEC source: 0001773751-25-000141 · wk-form4_1746050474.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,103 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $36.07 - $36.79. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 22:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 50,000 | $2.43 | $121,500.00 |
DisclosureSEC source: 0001773751-25-000141 · wk-form4_1746050474.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 22:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 41,667 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000141 · wk-form4_1746050474.xml · derivative · entry 14 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,131,399 Underlying: Class A Common Stock · 41,667 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F3 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 22:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 41,667 | $30.19 | $1,257,760.06 |
DisclosureSEC source: 0001773751-25-000141 · wk-form4_1746050474.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,103 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 22:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 41,667 | $2.43 | $101,250.81 |
DisclosureSEC source: 0001773751-25-000141 · wk-form4_1746050474.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| April 16, 2025 Filed Apr 18, 2025 19:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 16,667 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · derivative · entry 15 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,173,066 Underlying: Class A Common Stock · 16,667 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F6 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. Read SEC document |
| April 16, 2025 Filed Apr 18, 2025 19:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 17,001 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · derivative · entry 14 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,011 Underlying: Class A Common Stock · 17,001 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| April 16, 2025 Filed Apr 18, 2025 19:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 47,534 | $28.23 | $1,342,093.97 |
DisclosureSEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · nonDerivative · entry 5 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 332,728 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.885 - $28.605. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 16, 2025 Filed Apr 18, 2025 19:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 2,792 | $28.31 | $79,032.03 |
DisclosureSEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,103 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.15 - $28.525. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 16, 2025 Filed Apr 18, 2025 19:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 33,668 | $28.02 | $943,421.13 |
DisclosureSEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,895 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.83 - $28.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 16, 2025 Filed Apr 18, 2025 19:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 16,667 | $2.43 | $40,500.81 |
DisclosureSEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| April 16, 2025 Filed Apr 18, 2025 19:40 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 17,001 | $2.43 | $41,312.43 |
DisclosureSEC source: 0001773751-25-000124 · wk-form4_1745005205.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 21,047 | $34.13 | $718,350.95 |
DisclosureSEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · nonDerivative · entry 14 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,895 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F11 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $34.00 - $34.37. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 57,713 | $33.75 | $1,947,848.38 |
DisclosureSEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · nonDerivative · entry 13 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,942 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F10 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.33 - $33.995. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 16,667 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · derivative · entry 35 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,189,733 Underlying: Class A Common Stock · 16,667 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F20 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. F19 · derivative.expiration_date: The expiration date of the stock options was reported as 6/17/2030 instead of 6/16/2030 on Form 4s filed for transactions executed on June 6, 2023; June 29, 2023; July 18, 2023; August 8, 2023; November 30, 2023; December 27, 2023; January 25, 2024; February 12, 2024; March 1, 2024; April 4, 2024; May 1, 2024; June 4, 2024; July 3, 2024; August 5, 2024; September 3, 2024; October 1, 2024; November 5, 2024; December 13, 2024; January 16, 2025; and February 18, 2025, due to a software error. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 41,667 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · derivative · entry 34 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,206,400 Underlying: Class A Common Stock · 41,667 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F20 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. F19 · derivative.expiration_date: The expiration date of the stock options was reported as 6/17/2030 instead of 6/16/2030 on Form 4s filed for transactions executed on June 6, 2023; June 29, 2023; July 18, 2023; August 8, 2023; November 30, 2023; December 27, 2023; January 25, 2024; February 12, 2024; March 1, 2024; April 4, 2024; May 1, 2024; June 4, 2024; July 3, 2024; August 5, 2024; September 3, 2024; October 1, 2024; November 5, 2024; December 13, 2024; January 16, 2025; and February 18, 2025, due to a software error. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · derivative · entry 33 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,248,067 Underlying: Class A Common Stock · 50,000 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F20 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020. F19 · derivative.expiration_date: The expiration date of the stock options was reported as 6/17/2030 instead of 6/16/2030 on Form 4s filed for transactions executed on June 6, 2023; June 29, 2023; July 18, 2023; August 8, 2023; November 30, 2023; December 27, 2023; January 25, 2024; February 12, 2024; March 1, 2024; April 4, 2024; May 1, 2024; June 4, 2024; July 3, 2024; August 5, 2024; September 3, 2024; October 1, 2024; November 5, 2024; December 13, 2024; January 16, 2025; and February 18, 2025, due to a software error. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 17,001 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · derivative · entry 32 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136,012 Underlying: Class A Common Stock · 17,001 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F18 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. F19 · derivative.expiration_date: The expiration date of the stock options was reported as 6/17/2030 instead of 6/16/2030 on Form 4s filed for transactions executed on June 6, 2023; June 29, 2023; July 18, 2023; August 8, 2023; November 30, 2023; December 27, 2023; January 25, 2024; February 12, 2024; March 1, 2024; April 4, 2024; May 1, 2024; June 4, 2024; July 3, 2024; August 5, 2024; September 3, 2024; October 1, 2024; November 5, 2024; December 13, 2024; January 16, 2025; and February 18, 2025, due to a software error. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 7,087 | $34.15 | $242,015.38 |
DisclosureSEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · nonDerivative · entry 16 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 380,262 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F13 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $34.01 - $34.60. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 40,447 | $33.55 | $1,357,154.59 |
DisclosureSEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · nonDerivative · entry 15 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Dudum Family Community Property Trust Disclosed balance after: 387,349 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F12 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.20 - $33.975. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 22:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 2,792 | $33.01 | $92,159.73 |
DisclosureSEC source: 0001773751-25-000101 · wk-form4_1742337321.xml · nonDerivative · entry 12 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 173,655 F3 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F9 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $32.84 - $33.21. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.